Israel’s Ministry of Health Approves ESE to Test Terpene Mix Against a Coronavirus Strain
Next Investors
Archived
Aug 01, 2021
eSense-Lab Ltd (ASX: ESE) has signed a research agreement with the Israeli Ministry of Health to commence a research project at the Central Virology lab in the Chaim Sheba Medical Centre — the largest hospital in Israel — to test its proprietary TRP-ENV™ compounds for a coronaviruses.